Konstantopoulos K, Vogazianos P, Doskas T
Speech Therapy, European University Cyprus, Nicosia, Cyprus.
Arch Clin Neuropsychol. 2016 May;31(3):246-53. doi: 10.1093/arclin/acw002. Epub 2016 Feb 17.
The Montreal Cognitive Assessment (MoCA) is a brief cognitive instrument for the measurement of dementia. The aim of the present study is to provide normative data for the MoCA test in the Greek speaking population and to measure its validity in a clinical group of parkinsonian dementia participants. A total of 710 healthy Greek speaking participants and 19 parkinsonian dementia participants took part in the study. Both, the MoCA test and a neuropsychological test battery (digit span, semantic verbal fluency, phonemic verbal fluency, Color Trails Test) were administered to the normative and clinical samples. The test was found to correlate with all neuropsychological tests used in the test battery and it showed high discriminant validity (optimal screening cutoff point = 21, sensitivity = 0.82, specificity = 0.90) in the parkinsonian dementia participants. Further research is needed to use it in larger clinical samples and in different neurological diseases.
蒙特利尔认知评估量表（MoCA）是一种用于测量痴呆症的简易认知工具。本研究的目的是提供希腊语人群中MoCA测试的常模数据，并在帕金森病痴呆症参与者的临床组中评估其有效性。共有710名讲希腊语的健康参与者和19名帕金森病痴呆症参与者参与了该研究。对常模组和临床组样本均进行了MoCA测试以及一套神经心理学测试（数字广度、语义言语流畅性、音素言语流畅性、色词测验）。结果发现该测试与测试组中使用的所有神经心理学测试均相关，并且在帕金森病痴呆症参与者中显示出高鉴别效度（最佳筛查临界值 = 21，敏感性 = 0.82，特异性 = 0.90）。需要进一步研究以将其应用于更大规模的临床样本和不同的神经系统疾病中。
